BIOSTROPHIN Trademark

Trademark Overview

On Tuesday, August 2, 2005, a trademark application was filed for BIOSTROPHIN with the United States Patent and Trademark Office. The USPTO has given the BIOSTROPHIN trademark a serial number of 78683525. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 7, 2014. This trademark is owned by Asklepios Biopharmaceutical, Inc.. The BIOSTROPHIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a therapeutic treatment for duchenne's muscular dystrophy
biostrophin

General Information

Serial Number78683525
Word MarkBIOSTROPHIN
Filing DateTuesday, August 2, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 7, 2014
Registration Number3406791
Registration DateTuesday, April 1, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, a therapeutic treatment for duchenne's muscular dystrophy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 7, 2014
Primary Code005
First Use Anywhere DateWednesday, June 30, 2004
First Use In Commerce DateThursday, August 18, 2005

Trademark Owner History

Party NameAsklepios Biopharmaceutical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27514
Party NameAsklepios Biopharmaceutical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27514
Party NameAsklepios Biopharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27514

Trademark Events

Event DateEvent Description
Friday, November 7, 2014CANCELLED SEC. 8 (6-YR)
Tuesday, April 1, 2008REGISTERED-PRINCIPAL REGISTER
Monday, February 25, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, February 23, 2008ASSIGNED TO LIE
Thursday, January 24, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 3, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 3, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 3, 2008TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 19, 2007NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 19, 2007FINAL REFUSAL E-MAILED
Wednesday, September 19, 2007SU - FINAL REFUSAL - WRITTEN
Saturday, September 8, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 13, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 13, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 17, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2007NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2007SU - NON-FINAL ACTION - WRITTEN
Tuesday, July 17, 2007STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 21, 2007USE AMENDMENT FILED
Wednesday, March 21, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, December 12, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2006NOTICE OF PUBLICATION
Friday, July 28, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 28, 2006ASSIGNED TO LIE
Monday, July 10, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 16, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 11, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 17, 2006COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Tuesday, May 16, 2006ASSIGNED TO LIE
Thursday, May 11, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 10, 2006EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, May 10, 2006EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, April 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 30, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 30, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 30, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 30, 2006NON-FINAL ACTION E-MAILED
Thursday, March 30, 2006NON-FINAL ACTION WRITTEN
Monday, March 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 10, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 10, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 21, 2006NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2006NON-FINAL ACTION WRITTEN
Tuesday, February 21, 2006ASSIGNED TO EXAMINER
Monday, August 8, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

biostrophin duchenne muscular dystrophy treatment therapeutic preparations namely pharmaceutical